Stanford University
Showing 10,101-10,120 of 13,146 Results
-
Vidushi Savant
Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry
BioDr. Savant specializes in the treatment of comorbid psychiatric disorders in medically ill patients.
She is a double board certified in Psychosomatic Medicine and General Psychiatry. -
Amitoj Singh
Ph.D. Student in Stem Cell Biology and Regenerative Medicine, admitted Autumn 2024
BioAmitoj is a PhD student studying Stem Cell Biology at the Stanford University School of Medicine. He is interested in pursuing research projects in the field of cardiovascular medicine and regenerative therapeutics.
-
Anjali Bhatt Saxena, MD FASN
Clinical Professor (Affiliated), Medicine - Med/Nephrology
BioDr. Anjali Bhatt Saxena, MD is a Clinical Professor of Medicine (Affiliated) at Stanford University School of Medicine and the Director of Peritoneal Dialysis at the Santa Clara Valley Medical Center in San Jose, California. She has served as the Medical Director for an independent Peritoneal Dialysis (PD) Clinic in San Jose, CA since 2004, overseeing a large Peritoneal Dialysis clinic.
Dr. Saxena's clinical and research interests are in the area of home dialysis, including Peritoneal Dialysis and Home Hemodialysis. She is devoted to sharing her home dialysis expertise through research and education worldwide. She has been a key faculty member of Home Dialysis University (HDU) since 2007, providing home dialysis education to hundreds of US Nephrology Fellows and Nephrologists at all levels of experience; in 2024 she became HDU Program Director. She serves on the ASN Home Dialysis Steering Committee and is a founding member of the International Home Dialysis Consortium (ISN-ISPD). She has delivered numerous invited lectures at international meetings and has published scholarly work on PD in various peer-reviewed journals. Dr. Saxena is dedicated to the growth of PD worldwide; she is the immediate past-Treasurer for the International Society for Peritoneal Dialysis (ISPD) and Past-President of the N. American Chapter of ISPD. She is an Educational Ambassador for the ISN, and with colleagues supported the growth of PD in low income areas of Sri Lanka. -
Parnika Prashasti Saxena
Clinical Professor, Psychiatry and Behavioral Sciences
BioParnika Saxena is board certified in general and geriatric psychiatry. She completed her residency at St Elizabeth's Medical Center (affiliated with Tufts University School of Medicine) in Massachusetts and a clinical geriatric fellowship at the University of California, Los Angeles. She also worked as a research fellow in Clinical Psychopharmacology at Mclean Hospital (affiliated with Harvard Medical School) and also completed a psychoanalytic psychotherapy fellowship from the Boston Psychoanalytic Society and Institute. Her primary research interests lie in pharmacological and interventional treatments for resistant depression. At Stanford, she works on the inpatient service, outpatient geropsychiatry clinic and the electroconvulsive therapy service. She also serves at the program director of the Geriatric Psychiatry Fellowship. In addition to her clinical and research interests, she is passionate about patient advocacy and promoting mental health legislative changes to benefit patient care and has testified in state senate hearings to that end as a physician representative of organizations like the Northern California Psychiatric Association and American Psychiatric Association.
-
Nazish Sayed MD, PhD
Associate Professor (Research) of Surgery (Vascular Surgery)
Current Research and Scholarly InterestsThe Sayed Laboratory investigates how endothelial dysfunction contributes to cardiovascular disease and leverages human stem cell technologies to identify novel therapeutic strategies. Our research integrates patient-derived induced pluripotent stem cells (iPSCs), engineered cardiac tissues, organoids, human biospecimens, and multi-omic technologies to uncover mechanisms underlying inherited and acquired cardiovascular diseases.
A major focus of the laboratory is understanding endothelial–cardiomyocyte communication in cardiomyopathy. Using patient-specific iPSCs, human cardiac organoids, engineered heart tissues, spatial transcriptomics, and single-cell multi-omics, we study how endothelial dysfunction drives myocardial fibrosis, inflammation, and heart failure. Current efforts include investigations into LMNA-related dilated cardiomyopathy, endothelial-to-mesenchymal transition (EndoMT), and mechanisms of fibrotic remodeling.
A second major area of research is cardio-oncology. The laboratory develops human disease models to understand cardiovascular complications associated with cancer therapies, including tyrosine kinase inhibitors and immune checkpoint inhibitors. These studies have identified novel vascular mechanisms underlying treatment-related hypertension, cardiomyopathy, and heart failure.
The laboratory also investigates cardiovascular aging, toxic environmental exposures, rare vascular diseases, and regenerative medicine. By integrating human tissues, advanced stem cell models, genome engineering, spatial biology, and artificial intelligence–enabled multi-omic analyses, our goal is to develop precision therapeutic strategies that improve cardiovascular health and patient outcomes. -
Michael Scahill
Clinical Assistant Professor, Pediatrics - Neonatology
BioOn a trip to Mozambique while in med school here at Stanford, Dr Scahill saw the power of market interventions to transform healthcare. This led to his current focus on technology, data & AI. A veteran data scientist, his research trawls the oceans of data each patient generates for patterns to predict dangerous outcomes before they happen in Stanford's top level NICU, where he also still serves as a frontline clinician. Outside Stanford, he is the digital lead at Valley Children's hospital and advises health technology startups in Silicon Valley and beyond.
-
John Scandling
Professor of Medicine (Nephrology) at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsTolerance induction in clinical kidney transplantation
-
Blake K. Scanlon, Ph.D.
Adjunct Lecturer, Psych/Public Mental Health & Population Sciences
BioThe overarching aim of Dr. Scanlon’s research is to develop and evaluate low-cost, pragmatic and clinically translatable methods for improving management of neurodegenerative disease and dementia. To that end, the Caregiver Technology Division of the Scanlon Lab aims to enhance patient- and family-centered care through novel, broadly customizable, and highly scalable caregiver interventions. In parallel, the Neurodegenerative Division of the Scanlon Lab focuses on the development and application of cognitive, neuropsychiatric, and biological markers for the initiation and progression of neurodegeneration.
Dr. Scanlon received his bachelor’s degree in Neuroscience and doctorate in Clinical Health Psychology from the University of Miami. After concluding his clinical internship in Geropsychology/Neuropsychology at the VA Palo Alto Health Care System (VAPAHCS), he completed fellowships in Aging and Dementia at Stanford University School of Medicine and VAPAHCS. Dr. Scanlon is currently a VA Career Development Awardee in the Sierra-Pacific Mental Illness Research, Education, and Clinical Center (MIRECC) and Stanford/VA Aging Clinical Research Center where his work focuses on developing and evaluating low-cost, pragmatic and clinically translatable methods for improving management of neurodegenerative disease and dementia. He also serves as Co-Director of the Stanford/VA California Alzheimer's Disease Center, Chair of the VAPAHCS Dementia Committee, and Co-Chair of the Department of Veterans Affairs VISN 21 Dementia Committee.
